Agilent to expand state-of-the-art manufacturing capacity for nucleic acid-based therapeutics

Agilent to expand state-of-the-art manufacturing capacity for nucleic acid-based therapeutics

FREDERICK/SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced it will expand its state-of-the-art production facility in Frederick that develops and manufactures... Read More

Tuesday August 18, 2020 0 comments Tags: Frederick, Agilent Technologies, Sam Raha